RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
DMK Pharmaceuticals Stock

DMK Pharmaceuticals Equity 2024

DMK Pharmaceuticals Equity

-649,999.98 USD

Ticker

DMKPQ

ISIN

US00547W3079

WKN

A3EEVQ

In 2024, DMK Pharmaceuticals's equity was -649,999.98 USD, a -102.51% increase from the 25.88 M USD equity in the previous year.

DMK Pharmaceuticals Aktienanalyse

What does DMK Pharmaceuticals do?

DMK Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing DMK Pharmaceuticals's Equity

DMK Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding DMK Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating DMK Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

DMK Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in DMK Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about DMK Pharmaceuticals stock

What is the equity of DMK Pharmaceuticals this year?

DMK Pharmaceuticals has equity of -649,999.98 USD this year.

What was the equity of DMK Pharmaceuticals compared to the previous year?

The equity of DMK Pharmaceuticals has increased/decreased by -102.51% decreased compared to the previous year.

What impact does a high equity have on investors of DMK Pharmaceuticals?

A high equity is advantageous for investors of DMK Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of DMK Pharmaceuticals?

A low equity can be a risk for investors of DMK Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of DMK Pharmaceuticals affect the company?

An increase in equity of DMK Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of DMK Pharmaceuticals affect the company?

A reduction in equity of DMK Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of DMK Pharmaceuticals?

Some factors that can affect the equity of DMK Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of DMK Pharmaceuticals so important for investors?

The equity of DMK Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can DMK Pharmaceuticals take to change the equity?

To change equity, DMK Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does DMK Pharmaceuticals pay?

Over the past 12 months, DMK Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, DMK Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of DMK Pharmaceuticals?

The current dividend yield of DMK Pharmaceuticals is .

When does DMK Pharmaceuticals pay dividends?

DMK Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of DMK Pharmaceuticals?

DMK Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of DMK Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is DMK Pharmaceuticals located?

DMK Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von DMK Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of DMK Pharmaceuticals from 9/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/21/2024.

When did DMK Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/21/2024.

What was the dividend of DMK Pharmaceuticals in the year 2023?

In the year 2023, DMK Pharmaceuticals distributed 0 USD as dividends.

In which currency does DMK Pharmaceuticals pay out the dividend?

The dividends of DMK Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von DMK Pharmaceuticals

Our stock analysis for DMK Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DMK Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.